Company Overview and News

 
Short-covering rally may extend this week; 5 stocks for double-digit returns

2018-10-15 moneycontrol
The Indian market witnessed massive pullback on October 12 in spite of weakness in the US market. Amidst a heavy volatility, Nifty managed to close with 1.5 percent gain in the week at 10,472.5.
500182 505890 532187 KENNAMET INDUSINDBK SMLISUZU 505192 HEROMOTOCO CPICQ HRTQY

 
SML Isuzu Limited - Monthly Business Updates

2018-10-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
Ideas for Profit: PPAP Automotive is attractively valued; outlook strong

2018-09-27 moneycontrol
PPAP Automotive (PPAP) is a provider of automotive sealing systems and interior and exterior automotive parts. It caters to all major auto manufacturers in the passenger vehicle (PV) space. With its numero uno status, product portfolio indispensable to any vehicle, strong clientele, best-in-industry operating performance, positive industry outlook and extremely reasonable valuation, the company is a worthy contender for the long term.
505141 MARUTI PPAP SMLISUZU 505192 532934 MRZUY SCOOTER 532500

 
SML Isuzu sees new truck segment delivering growth

2018-09-26 thehindubusinessline
Light and Medium Commercial Vehicle player SML Isuzu hopes to surpass its previous domestic and export sales high during this fiscal, supported by the launch of new global series trucks, market penetration and a favourable outlook.
SMLISUZU 505192

 
SML Isuzu drives into South India with global model of lorry

2018-09-07 moneycontrol
Automobile major SML Isuzu Friday entered the South Indian market with a goods transporter of the global series, capitalising on the changing demands of the Indian lorry industry.
SMLISUZU 505192

 
SML Isuzu Limited - Monthly Business Updates

2018-09-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
Blue Lotus Capital hits final close of $35 million for PIPE fund

2018-08-16 livemint
Mumbai: Blue Lotus Capital, an asset management company focusing on private investments in public enterprises (PIPE) strategy, has raised $35 million (₹240 crore) for its Blue Lotus Capital Multibagger Fund, a senior company executive said.
ENKEIWHEL SMLISUZU 505192 533477

 
SML Isuzu Limited - Shareholders meeting

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
SML Isuzu Limited - Updates

2018-08-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
SML Isuzu Limited - Updates

2018-08-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
SML Isuzu Limited - Financial Result Updates

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
Jet Air, GTL, MRF, Sundaram Brake results

2018-08-08 thehindubusinessline
3M India, 63 Moons, Amrutanjan, Aurobindo Pharma, Bajaj Electricals, Bajaj Hindusthan, Bharat Forge, Coffee Day, Cummins India, Engineers India, GNFC, Godrej Agro, GTL, GTL Infra, Hindustan Copper, Indian Energy, IPCA Labs, Jet Airways, Jindal Steel, Manappuram, MRF, Page Ind, PNB Housing, SML Isuzu, Sundaram Brake, Sundram Fasteners, TTK Health, United Bank, Venky’s, VA Tech and Whirlpool are among the 215 firms that will declare their April-June results on Thursday.
HINDCOPPER AUROPHARMA 500403 UDBKL 524804 532617 505192 513599 UBLS JETAIRWAYS 532178 500480 CMQMY SUNDRMFAST ENGINERSIN SMLISUZU UBLA ARBQY CUMMINSIND 500031 500493 BAJAJELEC BHARATFORG

 
SML Isuzu Limited - Monthly Business Updates

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

 
SML Isuzu Limited - Trading Window

2018-07-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SMLISUZU 505192

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...